Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
-822K
-
Total reported value, excl. options
-
$106M
-
Value change
-
-$4.7M
-
Put/Call ratio
-
0.6
-
Number of buys
-
34
-
Number of sells
-
-29
-
Price
-
$4.04
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2017
89 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q2 2017.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 386M outstanding shares and own 6.81% of the company stock.
Largest 10 shareholders include LEVIN CAPITAL STRATEGIES, L.P. (5.76M shares), PRIMECAP MANAGEMENT CO/CA/ (4.28M shares), Russell Investments Group, Ltd. (2.35M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.95M shares), Neuberger Berman Group LLC (1.85M shares), BlackRock Inc. (1.84M shares), ORBIMED ADVISORS LLC (1.75M shares), VANGUARD GROUP INC (652K shares), RENAISSANCE TECHNOLOGIES LLC (531K shares), and STATE STREET CORP (500K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.